首页 | 本学科首页   官方微博 | 高级检索  
     

氯氧喹通过下调Rho/Rho激酶信号通路抑制乳腺癌细胞转移
引用本文:刘婧雯,杨兴莲,沈凯莉,曾玲晖,孙燕. 氯氧喹通过下调Rho/Rho激酶信号通路抑制乳腺癌细胞转移[J]. 浙江大学学报(医学版), 2019, 48(6): 631-637. DOI: 10.3785/j.issn.1008-9292.2019.12.07
作者姓名:刘婧雯  杨兴莲  沈凯莉  曾玲晖  孙燕
作者单位:1. 浙江大学城市学院医学院, 浙江 杭州 3100152. 浙江省肿瘤医院综合肿瘤内科, 浙江 杭州 310022
基金项目:浙江省医药卫生科技计划(2015RCB004);杭州市留学回国人员资助项目(2018)
摘    要:目的: 通过观察氯氧喹对乳腺癌细胞系细胞骨架的聚合状态及其对Rho/Rho激酶信号通路相关靶点蛋白磷酸化的作用,明确氯氧喹治疗乳腺癌的作用机制。方法: 以不同浓度氯氧喹处理乳腺癌Bcap37和MDA-MB-453细胞系,划痕试验检测细胞迁移,Transwell试验检测细胞侵袭,罗丹明标记鬼笔环肽染色法观察F肌动蛋白的聚解状态,免疫荧光法观察α微管蛋白的表达,蛋白质印迹法检测Rho/Rho激酶信号通路关键蛋白磷酸化水平。结果: 氯氧喹可剂量依赖性地抑制细胞迁移和侵袭;Bcap37和MDA-MB-453细胞经氯氧喹处理后其细胞形态发生改变,细胞体积减少;F肌动蛋白和α微管蛋白染色形态不规则,荧光染色聚集成团,且呈现剂量依赖性;氯氧喹可下调Rho/Rho激酶信号通路中肌动蛋白解聚因子Cofilin、磷酸化蛋白激酶(Limk)、Rho关联卷曲蛋白激酶2(Rock2)磷酸化表达(均P < 0.01)。结论: 氯氧喹可抑制乳腺癌细胞骨架聚合从而抑制细胞迁移,该作用可能与抑制Rho/Rho激酶信号通路相关。

关 键 词:乳腺肿瘤/病理学  细胞骨架  rho相关激酶类/拮抗剂和抑制剂  信号传导/药物作用  肌动蛋白类  微管蛋白  抗肿瘤药/药理学  
收稿时间:2019-07-15

Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway
LIU Jingwen,YANG Xinglian,SHEN Kaili,ZENG Linghui,SUN Yan. Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway[J]. Journal of Zhejiang University. Medical sciences, 2019, 48(6): 631-637. DOI: 10.3785/j.issn.1008-9292.2019.12.07
Authors:LIU Jingwen  YANG Xinglian  SHEN Kaili  ZENG Linghui  SUN Yan
Affiliation:1. School of Medicine, Zhejiang University City College, Hangzhou 310015, China2. Department of Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China
Abstract:Objective: To investigate the effect of chloroxoquinoline on cytoskeleton of breast cancer cells and its relation with Rho/Rho kinase signaling pathway. Methods: Breast cancer Bcap37 and MDA-MB-453 cells were treated with different concentrations of chloroxoquinoline. Wound healing and Transwell assay were conducted to detect cell migration and invasion, respectively. Rhodamine-phalloidin staining and immunofluorescent staining were used to observe the polymerization state of F-actin and the expression of α-Tublin in breast cancer cells, respectively. Western blot was used to detect the phosphorylation level of key protein in Rho/Rho kinase signaling pathway. Results: Compared with the control group, chloroxoquinoline treatment induced dose-dependent decrease in cell migration and invasion, and Bcap37 and MDA-MB-453 cells treated with chloroxoquinoline showed dose-dependent changes in cell morphology and decrease in cell body. The staining of F-actin and α-Tublin was irregular and clustered. Furthermore, treatment of chloroxoquinoline down-regulated the phosphorylation of the Rho/Rho kinase signaling proteins Cofilin, Limk and Rock2 (all P < 0.01). Conclusions: Chloroxoquinoline inhibits the cytoskeleton in breast cancer Bcap37 and MDA-MB-453 cells and inhibits cell migration. This effect may be associated with down-regulation of Rho/Rho kinase signaling pathway.
Keywords:Breast neoplasms/pathology  Cytoskeleton  rho-Associated kinases/antagonists & inhibitors  Signal transduction/drug effects  Actins  Tubulin  Antineoplastic agents/pharmacology  
点击此处可从《浙江大学学报(医学版)》浏览原始摘要信息
点击此处可从《浙江大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号